Dallemagne P - Search Results

1

Design and synthesis of a new type of non steroidal human aromatase inhibitors.

Sonnet P, Guillon J, Enguehard C, Dallemagne P, Bureau R, Rault S Auvray P, Moslemi S, Sourdiane P, Galopin S, Séralini GE. Sonnet P, et al. Among authors: dallemagne p. Bioorg Med Chem Lett. 1998 May 5;8(9):1041-4. doi: 10.1016/s0960-894x(98)00157-7. Bioorg Med Chem Lett. 1998. PMID: 9871704

2

Synthesis and evaluation of the CNS activity of new 4-alkoxyphenylimidazolidin-2-ones.

Guillon J, Lelong V, Renault O, Boulouard M, Dallemagne P, Rault S, Robba M. Guillon J, et al. Among authors: dallemagne p. Chem Pharm Bull (Tokyo). 1998 Apr;46(4):711-4. doi: 10.1248/cpb.46.711. Chem Pharm Bull (Tokyo). 1998. PMID: 9579047

3

MR 20492 and MR 20494: two indolizinone derivatives that strongly inhibit human aromatase.

Auvray P, Sourdaine P, Moslemi S, Séralini GE, Sonnet P, Enguehard C, Guillon J, Dallemagne P, Bureau R, Rault S. Auvray P, et al. Among authors: dallemagne p. J Steroid Biochem Mol Biol. 1999 Jul-Aug;70(1-3):59-71. doi: 10.1016/s0960-0760(99)00093-x. J Steroid Biochem Mol Biol. 1999. PMID: 10529003

4

New aromatase inhibitors. Synthesis and biological activity of aryl-substituted pyrrolizine and indolizine derivatives.

Sonnet P, Dallemagne P, Guillon J, Enguehard C, Stiebing S, Tanguy J, Bureau R, Rault S, Auvray P, Moslemi S, Sourdaine P, Séralini GE. Sonnet P, et al. Among authors: dallemagne p. Bioorg Med Chem. 2000 May;8(5):945-55. doi: 10.1016/s0968-0896(00)00024-9. Bioorg Med Chem. 2000. PMID: 10882007

5

Synthesis of new 2-(aminomethyl)-4-phenylpyrrolo[1,2-a]-quinoxalines and their preliminary in-vivo central dopamine antagonist activity evaluation in mice.

Guillon J, Boulouard M, Lisowski V, Stiebing S, Lelong V, Dallemagne P, Rault S. Guillon J, et al. Among authors: dallemagne p. J Pharm Pharmacol. 2000 Nov;52(11):1369-75. doi: 10.1211/0022357001777522. J Pharm Pharmacol. 2000. PMID: 11186245

6

Synthesis and preliminary behavioural evaluation in mice of new 3-aryl-3-pyrrol-1-ylpropanamides, analogues of FGIN-1-27 and FGIN-1-43.

Guillon J, Boulouard M, Lelong V, Dallemagne P, Rault S, Jarry C. Guillon J, et al. Among authors: dallemagne p. J Pharm Pharmacol. 2001 Nov;53(11):1561-8. doi: 10.1211/0022357011777945. J Pharm Pharmacol. 2001. PMID: 11732760

7

Synthesis of a novel class of non-peptide NK-2 receptor ligand, derived from 1-phenyl-3-pyrrol-1-ylindan-2-carboxamides.

Guillon J, Dallemagne P, Léger JM, Sopkova J, Bovy PR, Jarry C, Rault S. Guillon J, et al. Among authors: dallemagne p. Bioorg Med Chem. 2002 Apr;10(4):1043-50. doi: 10.1016/s0968-0896(01)00360-1. Bioorg Med Chem. 2002. PMID: 11836113

8

Study of substrate specificity of human aromatase by site directed mutagenesis.

Auvray P, Nativelle C, Bureau R, Dallemagne P, Séralini GE, Sourdaine P. Auvray P, et al. Among authors: dallemagne p. Eur J Biochem. 2002 Mar;269(5):1393-405. doi: 10.1046/j.1432-1033.2002.02779.x. Eur J Biochem. 2002. PMID: 11874453 Free article.

9

Synthesis and biological evaluation of cyclopenta[c]thiophene related compounds as new antitumor agents.

Dallemagne P, Khanh LP, Alsaïdi A, Renault O, Varlet I, Collot V, Bureau R, Rault S. Dallemagne P, et al. Bioorg Med Chem. 2002 Jul;10(7):2185-91. doi: 10.1016/s0968-0896(02)00070-6. Bioorg Med Chem. 2002. PMID: 11983515

10

Synthesis and biological evaluation of five-membered heterocycles fused to cyclopenta[c]thiophene as new antitumor agents.

Dallemagne P, Khanh LP, Alsaïdi A, Varlet I, Collot V, Paillet M, Bureau R, Rault S. Dallemagne P, et al. Bioorg Med Chem. 2003 Apr 3;11(7):1161-7. doi: 10.1016/s0968-0896(02)00654-5. Bioorg Med Chem. 2003. PMID: 12628643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters